ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2013-03-15
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2013-03-15 (fiscal Q2 2013): 23 published measures, 81 facts as tagged in accession 0001104659-13-021235.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-03-15
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001104659-13-021235 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 10,705,395 | USD | |
| At 2012-07-31 | 7,428,737 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 2,689,421 | USD | |
| At 2012-07-31 | 3,002,472 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 8,015,974 | USD | |
| At 2012-07-31 | 4,426,265 | USD | |
| At 2011-07-31 | -2,364,876 | USD | |
| At 2010-07-31 | -30,059 | USD | |
| At 2009-07-31 | 6,099 | USD | |
| At 2008-07-31 | 39,813 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 8,982,142 | USD | |
| At 2012-07-31 | 5,141,509 | USD | |
| At 2012-01-31 | 456,242 | USD | |
| At 2011-07-31 | 2,457,693 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-08-01 to 2013-01-31 | 3,169 | USD | 184 |
| 2008-02-08 to 2013-01-31 | 127,966 | USD | 1820 |
| 2011-08-01 to 2012-01-31 | 20,199 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | -9,849,641 | USD | |
| At 2012-07-31 | -6,200,728 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | 102,895,957 | shares | 92 |
| 2012-08-01 to 2013-01-31 | 95,394,076 | shares | 184 |
| 2011-11-01 to 2012-01-31 | 56,856,000 | shares | 92 |
| 2011-08-01 to 2012-01-31 | 56,856,000 | shares | 184 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | 102,895,957 | shares | 92 |
| 2012-08-01 to 2013-01-31 | 95,394,076 | shares | 184 |
| 2011-11-01 to 2012-01-31 | 56,856,000 | shares | 92 |
| 2011-08-01 to 2012-01-31 | 57,020,251 | shares | 184 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | -0.02 | USD/shares | 92 |
| 2012-08-01 to 2013-01-31 | -0.04 | USD/shares | 184 |
| 2011-11-01 to 2012-01-31 | -0.05 | USD/shares | 92 |
| 2011-08-01 to 2012-01-31 | 0 | USD/shares | 184 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | -0.02 | USD/shares | 92 |
| 2012-08-01 to 2013-01-31 | -0.04 | USD/shares | 184 |
| 2011-11-01 to 2012-01-31 | -0.05 | USD/shares | 92 |
| 2011-08-01 to 2012-01-31 | 0 | USD/shares | 184 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-08-01 to 2013-01-31 | 2,000 | USD | 184 |
| 2008-02-08 to 2013-01-31 | 6,000 | USD | 1820 |
| 2011-11-01 to 2012-01-31 | 400 | USD | 92 |
| 2011-08-01 to 2012-01-31 | 2,400 | USD | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 61,633 | USD | |
| At 2012-07-31 | 76,911 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | -1,597,843 | USD | 92 |
| 2012-08-01 to 2013-01-31 | -3,595,319 | USD | 184 |
| 2008-02-08 to 2013-01-31 | -10,886,026 | USD | 1820 |
| 2011-11-01 to 2012-01-31 | -1,180,329 | USD | 92 |
| 2011-08-01 to 2012-01-31 | -2,374,567 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 9,133,511 | USD | |
| At 2012-07-31 | 5,493,056 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2008-02-08 to 2013-01-31 | 1,357 | USD | 1820 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 2,689,421 | USD | |
| At 2012-07-31 | 2,023,156 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 1,510,251 | USD | |
| At 2012-07-31 | 1,858,770 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 117,859,000 | shares | |
| At 2012-07-31 | 87,856,000 | shares | |
| At 2011-03-02 | 68,480,000 | shares | |
| At 2011-02-28 | 2,140,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-01-31 | 11,229,263 | USD | |
| At 2012-07-31 | 5,593,567 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | -1,621,988 | USD | 92 |
| 2012-08-01 to 2013-01-31 | -3,648,913 | USD | 184 |
| 2008-02-08 to 2013-01-31 | -9,849,641 | USD | 1820 |
| 2011-08-01 to 2012-07-31 | -2,364,852 | USD | 366 |
| 2011-11-01 to 2012-01-31 | -2,671,864 | USD | 92 |
| 2011-08-01 to 2012-01-31 | 40,182 | USD | 184 |
| 2010-08-01 to 2011-07-31 | -3,758,817 | USD | 365 |
| 2009-08-01 to 2010-07-31 | -36,158 | USD | 365 |
| 2008-08-01 to 2009-07-31 | -33,714 | USD | 365 |
| 2008-02-09 to 2008-07-31 | -7,187 | USD | 174 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | 983,622 | USD | 92 |
| 2012-08-01 to 2013-01-31 | 1,940,107 | USD | 184 |
| 2008-02-08 to 2013-01-31 | 6,177,665 | USD | 1820 |
| 2011-11-01 to 2012-01-31 | 671,923 | USD | 92 |
| 2011-08-01 to 2012-01-31 | 1,350,574 | USD | 184 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-01-31 | 9,000 | USD | 92 |
| 2012-08-01 to 2013-01-31 | 18,000 | USD | 184 |
| 2011-11-01 to 2012-01-31 | 8,000 | USD | 92 |
| 2011-08-01 to 2012-01-31 | 16,000 | USD | 184 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-08-01 to 2013-01-31 | 366,965 | USD | 184 |
| 2008-02-08 to 2013-01-31 | 1,335,238 | USD | 1820 |
| 2011-08-01 to 2012-01-31 | 350,151 | USD | 184 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))